Oura, the Finnish-American company behind the popular smart ring, announced on April 8, 2026, that it has built its first proprietary large language model dedicated entirely to women’s health. The model is folded into Oura Advisor, the AI chat feature already available inside the Oura app, and it is designed to answer questions about menstrual cycles, fertility, pregnancy and menopause using a combination of vetted medical research and each user’s own biometric data.
Why Oura built a separate model for women’s health
According to Oura’s announcement, the company built a dedicated model rather than relying on a general-purpose chatbot because women’s health questions are often nuanced, hormonally driven and poorly served by generic health information online. Ricky Bloomfield, Oura’s Chief Medical Officer, said in the company’s statement that “women’s health is too complex — and too often overlooked — to rely on one-size-fits-all systems.” Chris Curry, a board-certified OB/GYN who serves as Oura’s Clinical Director of Women’s Health, added that “women’s health questions are often deeply personal and high-stakes, and they deserve answers that can be trusted.”
How the model actually works
When a user asks the model a question — about irregular cycles, pregnancy symptoms or perimenopausal sleep disruption, for instance — it references curated, clinician-vetted research while simultaneously analyzing the person’s own sleep, activity, stress and cycle-tracking trends recorded by their ring. The result, Oura says, is a personalized answer intended to prepare the user for a more informed conversation with an actual doctor, rather than to replace one. Oura said the model runs on infrastructure the company controls, and that conversations are not shared with outside parties, an attempt to address the privacy concerns that have dogged period- and fertility-tracking apps in recent years.
The information gap it is trying to fill
Oura’s announcement cited a 2025 survey finding that nearly eight in ten U.S. adults search online for health information, and that almost two-thirds of them say they have encountered AI-generated answers in their search results already — often without knowing how reliable those answers are. That backdrop is central to Oura’s pitch: women asking Google or a general chatbot about, say, unusual bleeding patterns get generic, sometimes contradictory answers, whereas a model trained specifically on reproductive and hormonal health, paired with a person’s actual physiological data, could in theory give a more grounded response.
Reasons for caution
Health researchers and clinicians have repeatedly warned that AI chat tools, even ones built by device makers with genuine clinical oversight, can still produce confident-sounding but incorrect guidance, and that biometric-driven personalization only works as well as the sensors collecting the data — wearable accuracy for things like ovulation timing and pregnancy-related symptoms has itself been debated in medical literature. There is also the broader question of trust: fertility and cycle data are among the most sensitive categories of personal health information, and any company centralizing that data alongside a conversational AI product invites scrutiny over how the data could be used, subpoenaed or breached, regardless of what a company says its policy is today.
Part of a bigger AI buildout
The women’s health model is not a standalone project. Oura has said it has accumulated close to 42 billion hours of physiological data from its ring wearers, which it uses to train what it calls Health Foundation Models — the broader family of proprietary neural networks underpinning its AI features. The women’s health model launched alongside Oura’s continued expansion of Oura Advisor to its full membership base and arrives as the company has also been rolling out other AI-driven features, including predictive alerts for cardiovascular and respiratory changes.
What’s next
Oura’s move comes as the company has filed for an IPO targeting a valuation above $16 billion, according to reporting in September 2026, putting added pressure on its AI features to demonstrate real clinical value rather than function as marketing flourishes. Whether a purpose-built women’s health model meaningfully changes outcomes — as opposed to just changing the tone of an app’s chat responses — will likely take longer studies and independent validation to determine. In the meantime, competitors making fertility- and cycle-tracking wearables are widely expected to respond with their own specialized AI tools, turning women’s health into one of the more contested fronts in the wearable AI race.
